ES2193137T3 - Heteroaril aminas como nuevos inhibidors de acetilcolinesterasa. - Google Patents
Heteroaril aminas como nuevos inhibidors de acetilcolinesterasa.Info
- Publication number
- ES2193137T3 ES2193137T3 ES92918761T ES92918761T ES2193137T3 ES 2193137 T3 ES2193137 T3 ES 2193137T3 ES 92918761 T ES92918761 T ES 92918761T ES 92918761 T ES92918761 T ES 92918761T ES 2193137 T3 ES2193137 T3 ES 2193137T3
- Authority
- ES
- Spain
- Prior art keywords
- inhibidors
- acetilcolinesterasa
- aminas
- heteroaril
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
COMPUESTOS DE FORMULA (I), EN DONDE ANILLO A, ANILLO B, ANILLO D, R2, R3, R4, R5, R6, R11, R12, R13, E, G, X Y P SON COMO SE DEFINE EN LA MEMORIA. LOS COMPUESTOS DE FORMULA (I) SON INHIBIDORES DE COLINESTERASA Y SE USAN EN MEJORA DE MEMORIA EN PACIENTES QUE SUFREN DE DEMENCIA Y ENFERMEDAD DE ALZHEIMER.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77128391A | 1991-10-03 | 1991-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2193137T3 true ES2193137T3 (es) | 2003-11-01 |
Family
ID=25091318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92918761T Expired - Lifetime ES2193137T3 (es) | 1991-10-03 | 1992-08-31 | Heteroaril aminas como nuevos inhibidors de acetilcolinesterasa. |
Country Status (36)
Country | Link |
---|---|
US (4) | US5574046A (es) |
EP (1) | EP0606248B1 (es) |
JP (1) | JP2546785B2 (es) |
KR (1) | KR0170458B1 (es) |
CN (1) | CN1035615C (es) |
AP (1) | AP314A (es) |
AT (1) | ATE235490T1 (es) |
AU (1) | AU667053B2 (es) |
BG (1) | BG61727B1 (es) |
BR (1) | BR9206577A (es) |
CA (1) | CA2119647C (es) |
CZ (1) | CZ290807B6 (es) |
DE (2) | DE69232976T2 (es) |
DK (1) | DK0606248T3 (es) |
EG (1) | EG21481A (es) |
ES (1) | ES2193137T3 (es) |
FI (1) | FI116939B (es) |
HU (1) | HU225049B1 (es) |
IL (1) | IL103274A (es) |
IS (1) | IS1745B (es) |
MA (1) | MA22672A1 (es) |
MX (1) | MX9205678A (es) |
NO (1) | NO308533B1 (es) |
NZ (1) | NZ244601A (es) |
OA (1) | OA09895A (es) |
PH (1) | PH31290A (es) |
PL (3) | PL171669B1 (es) |
PT (1) | PT100917B (es) |
RO (1) | RO112868B1 (es) |
RU (1) | RU2100357C1 (es) |
SG (1) | SG52618A1 (es) |
TW (1) | TW263504B (es) |
UA (1) | UA41290C2 (es) |
UY (1) | UY23484A1 (es) |
WO (1) | WO1993007140A1 (es) |
ZA (1) | ZA927589B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620973A (en) * | 1993-11-30 | 1997-04-15 | Takeda Chemical Industries, Ltd. | Tetracyclic condensed heterocyclic compounds and their use |
EP0976404A3 (en) * | 1998-07-30 | 2001-06-27 | Pfizer Products Inc. | A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
CN1535682A (zh) | 1998-09-30 | 2004-10-13 | ����ҩƷ��ҵ��ʽ���� | 改善膀胱排泄能力的药物 |
CN1317276C (zh) * | 2000-09-29 | 2007-05-23 | 中国科学院上海药物研究所 | 一类吲哚基哌啶类化合物及其制备方法和用途 |
KR100823908B1 (ko) * | 2000-10-20 | 2008-04-21 | 바이오비트럼 에이비(피유비엘) | 2-, 3-, 4-, 또는 5-치환-n1-(벤젠술포닐)인돌 및 이의치료 용도 |
US20050215614A1 (en) * | 2002-10-15 | 2005-09-29 | Rigel Pharmaceuticals, Inc. | Substituted indoles and their use as hcv inhibitors |
US20060014801A1 (en) * | 2002-11-22 | 2006-01-19 | The Johns Hopkins University | Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs |
WO2005112908A1 (en) * | 2004-05-14 | 2005-12-01 | The Johns Hopkins University | Method for improving cognitive function |
EP1600447A1 (en) * | 2004-05-28 | 2005-11-30 | Neuropharma S.A.U. | Butyrylcholinesterase selective inhibitors |
DE602005010698D1 (de) | 2004-06-09 | 2008-12-11 | Glaxo Group Ltd | Pyrrolopyridinderivate |
EP1827468B1 (en) * | 2004-12-23 | 2012-08-22 | Curaxis Pharmaceutical Corporation | Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease |
CN1808106B (zh) * | 2005-01-21 | 2010-11-24 | 中国科学院上海药物研究所 | 一种用核磁共振筛选乙酰胆碱酯酶抑制剂的方法 |
US8846315B2 (en) | 2008-08-12 | 2014-09-30 | Zinfandel Pharmaceuticals, Inc. | Disease risk factors and methods of use |
SG193793A1 (en) | 2008-08-12 | 2013-10-30 | Zinfandel Pharmaceuticals Inc | Method of identifying disease risk factors |
CN101503414B (zh) * | 2009-03-04 | 2013-10-30 | 沈阳药科大学 | 噻唑并[3,2-b]-1,2,4-三嗪衍生物及其应用 |
CN103772312B (zh) | 2009-10-02 | 2016-08-17 | 埃维克辛公司 | 抗炎症的2-羰基噻唑和2-羰基恶唑 |
JP6082250B2 (ja) | 2010-02-09 | 2017-02-15 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 認知機能を改善するための方法および組成物 |
KR20180050420A (ko) | 2011-01-10 | 2018-05-14 | 진판델 파마슈티컬스 인코포레이티드 | 알츠하이머 병 치료를 위한 방법 및 약품 |
WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
KR102268357B1 (ko) | 2013-01-29 | 2021-06-23 | 아벡신 에이에스 | 항염증성 및 항종양성 2-옥소티아졸 및 2-옥소티오펜 화합물 |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
EP2968220B1 (en) | 2013-03-15 | 2021-05-05 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
CN103333163A (zh) * | 2013-07-09 | 2013-10-02 | 广州中医药大学 | 一种苯并呋喃类衍生物及其制备方法和应用 |
GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
CA2986598C (en) | 2015-05-22 | 2023-09-26 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
CN107141266B (zh) * | 2017-06-28 | 2019-04-09 | 佳木斯大学附属第一医院 | 一种用于治疗阿尔茨海默病的杂环化合物及其制备方法 |
CN115466211B (zh) * | 2022-06-09 | 2024-02-23 | 中国人民解放军空军军医大学 | 一种n-苯基喹啉-4-胺类化合物及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL100127C (es) * | 1954-04-28 | |||
FR2334358A1 (fr) * | 1975-12-12 | 1977-07-08 | Sogeras | Nouveaux medicaments derives de l'indole |
US4122265A (en) * | 1976-05-21 | 1978-10-24 | Hoffmann-La Roche Inc. | Derivatives of 3-phenylisoindole-1-carboxylic acid |
ZA815541B (en) * | 1980-08-12 | 1983-03-30 | Glaxo Group Ltd | Heterocyclic compounds |
GB8615562D0 (en) * | 1986-06-25 | 1986-07-30 | Maggioni Farma | Aminoalcohols |
KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
IT1226100B (it) * | 1988-07-07 | 1990-12-10 | Dompe Farmaceutici Spa | Derivati benzimidazolici farmacologicamente attivi. |
FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
US4908372A (en) * | 1988-10-13 | 1990-03-13 | Merrell Dow Pharmaceuticals Inc. | Antihistaminic piperidinyl benzimidazoles |
JP2969359B2 (ja) * | 1989-01-13 | 1999-11-02 | 武田薬品工業株式会社 | 環状アミン化合物 |
US5064840A (en) * | 1989-08-03 | 1991-11-12 | Merrell Dow Pharmaceuticals | Anti-psychotic piperidylbenzimidazole compounds |
TW197442B (es) * | 1990-02-08 | 1993-01-01 | Pfizer | |
US5116846A (en) * | 1990-03-28 | 1992-05-26 | Du Pont Merck Pharmaceutical Company | N-aralkyl piperidine derivatives as psychotropic drugs |
TW197435B (es) * | 1990-11-22 | 1993-01-01 | Takeda Pharm Industry Co Ltd | |
NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
AU669156B2 (en) * | 1992-02-13 | 1996-05-30 | Merrell Dow Pharmaceuticals Inc. | Piperidinyl thiacyclic derivatives |
CA2092112A1 (en) * | 1992-03-23 | 1993-09-24 | Nobuyoshi Iwata | Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use |
-
1992
- 1992-08-29 TW TW081106843A patent/TW263504B/zh active
- 1992-08-31 UA UA94005424A patent/UA41290C2/uk unknown
- 1992-08-31 CZ CZ1994785A patent/CZ290807B6/cs not_active IP Right Cessation
- 1992-08-31 RO RO94-00533A patent/RO112868B1/ro unknown
- 1992-08-31 DE DE69232976T patent/DE69232976T2/de not_active Expired - Fee Related
- 1992-08-31 ES ES92918761T patent/ES2193137T3/es not_active Expired - Lifetime
- 1992-08-31 CA CA002119647A patent/CA2119647C/en not_active Expired - Fee Related
- 1992-08-31 KR KR1019940701066A patent/KR0170458B1/ko not_active IP Right Cessation
- 1992-08-31 EP EP92918761A patent/EP0606248B1/en not_active Expired - Lifetime
- 1992-08-31 WO PCT/US1992/007230 patent/WO1993007140A1/en active IP Right Grant
- 1992-08-31 RU RU9494019972A patent/RU2100357C1/ru not_active IP Right Cessation
- 1992-08-31 SG SG1996006904A patent/SG52618A1/en unknown
- 1992-08-31 DE DE9290112U patent/DE9290112U1/de not_active Expired - Lifetime
- 1992-08-31 PL PL92303096A patent/PL171669B1/pl not_active IP Right Cessation
- 1992-08-31 US US08/211,044 patent/US5574046A/en not_active Expired - Lifetime
- 1992-08-31 JP JP5506442A patent/JP2546785B2/ja not_active Expired - Fee Related
- 1992-08-31 PL PL92312752A patent/PL171693B1/pl not_active IP Right Cessation
- 1992-08-31 DK DK92918761T patent/DK0606248T3/da active
- 1992-08-31 AT AT92918761T patent/ATE235490T1/de not_active IP Right Cessation
- 1992-08-31 HU HU9400952A patent/HU225049B1/hu unknown
- 1992-08-31 AU AU25196/92A patent/AU667053B2/en not_active Ceased
- 1992-08-31 PL PL92312751A patent/PL171984B1/pl not_active IP Right Cessation
- 1992-08-31 BR BR9206577A patent/BR9206577A/pt not_active Application Discontinuation
- 1992-09-07 AP APAP/P/1992/000421A patent/AP314A/en active
- 1992-09-15 PH PH44935A patent/PH31290A/en unknown
- 1992-09-24 IL IL10327492A patent/IL103274A/en not_active IP Right Cessation
- 1992-09-25 IS IS3919A patent/IS1745B/is unknown
- 1992-09-30 EG EG58192A patent/EG21481A/xx active
- 1992-09-30 CN CN92112079A patent/CN1035615C/zh not_active Expired - Fee Related
- 1992-10-01 PT PT100917A patent/PT100917B/pt not_active IP Right Cessation
- 1992-10-02 MX MX9205678A patent/MX9205678A/es unknown
- 1992-10-02 MA MA22956A patent/MA22672A1/fr unknown
- 1992-10-02 ZA ZA927589A patent/ZA927589B/xx unknown
- 1992-10-02 NZ NZ244601A patent/NZ244601A/en not_active IP Right Cessation
- 1992-10-02 UY UY23484A patent/UY23484A1/es not_active IP Right Cessation
-
1994
- 1994-03-18 OA OA60484A patent/OA09895A/en unknown
- 1994-03-30 NO NO941179A patent/NO308533B1/no unknown
- 1994-03-31 FI FI941518A patent/FI116939B/fi active IP Right Grant
- 1994-03-31 BG BG98689A patent/BG61727B1/bg unknown
-
1997
- 1997-10-24 US US08/957,639 patent/US6124321A/en not_active Expired - Fee Related
-
1999
- 1999-11-11 US US09/438,712 patent/US6303633B1/en not_active Expired - Fee Related
-
2001
- 2001-08-23 US US09/935,903 patent/US20020049210A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2193137T3 (es) | Heteroaril aminas como nuevos inhibidors de acetilcolinesterasa. | |
ES2053451T3 (es) | Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles. | |
ES2188584T3 (es) | Derivados heterociclicos de amina. | |
NO307968B1 (no) | Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav | |
DE69005858D1 (de) | Heterocyclische Verbindungen. | |
FI935585A0 (fi) | Pyrrolopyrimidiner | |
ES2097174T3 (es) | Derivados de la 2-ciclohexan-1-il amina. | |
DK0944643T3 (da) | Oxyiminopregnancarbolactoner. | |
FI923536A (fi) | Foerfarande foer analysering av gasprov, analyseringsanordning, dess anvaendning och en test anlaeggning med den naemnda analyseringsanordningen. | |
ATE218142T1 (de) | Nitratester von corticoid verbindungen und die therapeutische verwendungen davon | |
ES2107284T3 (es) | Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
DE69229339T2 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
FR2686425B1 (fr) | Source sismique de puits. | |
SE8904298D0 (sv) | New compounds | |
ES2183923T3 (es) | Derivados de cromona. | |
NO910473L (no) | Fremgangsmaate for fremstilling av tricykliske aminer. | |
NO913411D0 (no) | Akrylatestere av 1,1,1-trishydroksyfenyletan. | |
DE59010508D1 (de) | Heterocyclische metallorganische Verbindungen | |
TR199701298T1 (xx) | Tetralinler. | |
DE69024595D1 (de) | Träger für Entwickler, Herstellungsverfahren und den Träger verwendendes Entwicklungsverfahren | |
SU1825499A3 (ru) | Гидрохлорид n-(2-адамантил)гексаметиленимина, обладающий антикаталептической активностью | |
DE69019801D1 (de) | Heterocyclische Verbindungen. | |
DE59703824D1 (de) | Sulfonylbenzazolone | |
IT8820273A0 (it) | Procedimento di preparazione della n,n'_bis_(2_idrossietil)_piperazina . | |
SU1464319A1 (ru) | Коронароактивное антиишемическое средство |